GlassScriptPhysician profile
Holly L Steiner
NPI 1083907844
$10,420.08
in general payments reported to CMS, 2019-2025
29 companies · $145 in 2025
The $145 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $198 · 2020: $41.72 · 2021: $5.32 · 2023: $9,449 · 2024: $581 · 2025: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $7,500 · Food and Beverage: $1,630 · Travel and Lodging: $1,045.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $7,500.00 |
| Food and Beverage | $1,630.16 |
| Travel and Lodging | $1,045.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,716.78 | 2023-2024 | Davinci Xi, Da Vinci Surgical System |
| Organon LLC | $195.40 | 2021-2025 | Nexplanon |
| Astellas Pharma US INC | $188.57 | 2023-2025 | Veozah |
| Sumitomo Pharma America, INC. | $177.51 | 2023-2024 | Myfembree, Gemtesa |
| Mayne Pharma Commercial LLC | $152.70 | 2023 | |
| Abbvie INC. | $122.29 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Exeltis, USA INC. | $105.54 | 2020-2024 | Slynd |
| Shield Therapeutics INC | $82.99 | 2023-2024 | Accrufer |
| Sage Therapeutics, LLC | $67.56 | 2024-2025 | Zurzuvae |
| Avanos Medical | $63.54 | 2023-2024 | On-Q* Pump and Accessories |
| Exact Sciences Corporation | $54.17 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Conmed Corporation | $48.29 | 2023 | Airseal |
| Hologic Sales and Service, LLC | $43.33 | 2024-2025 | Myosure Tissue Removal Device, Aptima, Thinprep 2000 Processor |
| Meditrina | $39.05 | 2023 | |
| Dexcom, INC. | $37.67 | 2024 | Dexcom G6 Transmitter |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $36.05 | 2023-2025 | |
| Covidien LP | $35.27 | 2019 | |
| Minerva Surgical, INC | $34.11 | 2023 | |
| Boston Scientific Corporation | $33.26 | 2019 | |
| Therapeuticsmd, INC. | $28.22 | 2019 | |
| Convatec INC. | $25.18 | 2019 | |
| Agile Therapeutics, INC. | $22.69 | 2023 | Twirla |
| Lilly USA, LLC | $20.00 | 2024 | Zepbound |
| Medtronic, INC. | $17.47 | 2023 | V-Loc 180 |
| Vertex Pharmaceuticals Incorporated | $16.57 | 2024 | |
| Novo Nordisk INC | $15.25 | 2024 | |
| Pfizer INC. | $13.94 | 2023 | |
| Currax Pharmaceuticals LLC | $13.43 | 2023 | Contrave |
| Lsi Solutions INC | $13.25 | 2024 | Fornisee |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Holly Steiner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.